At the recent American Society of Clinical Oncology meeting (ASCO), Dr. David Carbone, Director of the James Thoracic Center, James Cancer Hospital and Solove Research Institute at Ohio State University Comprehensive Cancer Center and Dr. George Simon, Professor in the Department of Thoracic/Head and Neck Oncology at The University of Texas MD Anderson Cancer Center, share highlights from the meeting including what they call “progress on multiple fronts in lung cancer.” Dr. Carbone discusses how patients should demand a genetic workup on their tumor and his free genetic testing initiative at Ohio State. Dr. Simon shares how some immunotherapy and chemotherapy combinations are showing promise and how small cell lung cancer patients could potentially also benefit. Watch the video below to hear from two lung cancer experts.
From one of the largest educational and scientific events in the oncology community, we had the chance to sit down with a few prostate cancer experts to hear the latest news coming out of the ASCO 2017 conference. The panel included the following experts:
- Philip Kantoff, MD, Chair, Department of Medicine, Memorial Sloan Kettering Cancer Center
- Daniel Petrylak, MD, Director, Genitourinary Oncology, Co-Director, Signal Transduction Research Program, Yale University Cancer Center
- Sumit Subudhi, MD, Assistant Professor, Department of Genitourinary Medical Oncology, Division of CancerMedicine, The University of Texas MD Anderson Cancer Center
- Darryl Mitteldorf, LCSW, Executive Director, Malecare
The panel covers a variety of headline topics such as treatment options, prognostic factors, genetic marker, clinical trials, and more. Check out the full video to below to hear from four prostate cancer experts.